[Press Release]Samsung Biologics enters into a development and manufacturing partnership with PharmAbcine for oncology and neovascular treatment
7 Apr 2020
[Press Release]Samsung Biologics enters into a development and manufacturing partnership with PharmAbcine for oncology and neovascular treatment
2F, Research Building 2, 70,
Yuseong-daero 1689 beon-gil,
Yuseong-gu, Daejeon, 34047, Republic of Korea
HQ +82-42-863-2017
R&D Center +82-42-861-2017
Investor Relations +70-4294-6097
FAX +82-42-863-2080
COPYRIGHT BY PharmAbcine Inc.
ALL RIGHTS RESERVE
Samsung Biologics enters into a development and manufacturing partnership with PharmAbcine for oncology and neovascular treatment
Please check the below link.
CISION PR Newswire _ https://www.prnewswire.com/news-releases/samsung-biologics-enters-into-a-development-and-manufacturing-partnership-with-pharmabcine-for-oncology-and-neovascular-treatment-301034908.html
BioSpace _ https://www.biospace.com/article/releases/samsung-biologics-enters-into-a-development-and-manufacturing-partnership-with-pharmabcine-for-oncology-and-neovascular-treatment/?keywords=pharmabcine